Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)

SHA:603168 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	108.28	82.79	355.67	525.06	138.52	106.78
Short-Term Investments	-	-	-	-	-	100
Trading Asset Securities	76.74	106.86	13.53	29.27	105.03	250
Cash & Short-Term Investments	185.02	189.65	369.2	554.33	243.55	456.78
Cash Growth	-7.85%	-48.63%	-33.40%	127.60%	-46.68%	-33.07%
Accounts Receivable	53.55	67.79	53.58	40.32	52.04	112.96
Other Receivables	14.18	12.84	8.69	42.96	5.16	3.06
Receivables	67.73	80.62	62.27	83.28	57.2	116.02
Inventory	100.17	76.66	84.32	59.1	60.82	56.53
Other Current Assets	15.86	19.74	36.87	31.09	192.37	18.31
Total Current Assets	368.78	366.67	552.66	727.8	553.95	647.65
Property, Plant & Equipment	830.8	841.87	795.34	651.26	474.12	507.27
Long-Term Investments	325.7	327.64	232.14	67.86	-	-
Goodwill	332.09	332.09	365.43	326.68	336.16	336.16
Other Intangible Assets	149.13	150.41	154.62	160.14	165.72	177.29
Long-Term Deferred Tax Assets	1.11	0.78	0.74	0.82	0.07	0.08
Long-Term Deferred Charges	76.36	67.73	30.45	4.74	1.87	3.37
Other Long-Term Assets	21.38	19.07	38.91	17.18	53.47	1.09
Total Assets	2,105	2,106	2,170	1,956	1,585	1,673
Accounts Payable	146.25	137.04	123.11	80.85	25.93	33.88
Accrued Expenses	11.71	68.81	53.06	53.9	69.86	61.2
Short-Term Debt	89.65	105.29	85.98	-	-	-
Current Portion of Long-Term Debt	16.84	4.1	10.41	-	-	-
Current Portion of Leases	-	8.05	8.54	5.93	-	-
Current Income Taxes Payable	6.08	1.31	4.52	-	3.8	6.89
Current Unearned Revenue	13.06	19.71	26.39	49.75	34.49	33.39
Other Current Liabilities	69.64	33.16	55.68	15.39	61.2	226.57
Total Current Liabilities	353.21	377.47	367.7	205.82	195.27	361.92
Long-Term Debt	131.39	111.55	37.07	-	-	-
Long-Term Leases	19.31	25.34	33.68	33.76	37.61	-
Long-Term Unearned Revenue	2.16	2.22	2.47	-	-	2.63
Long-Term Deferred Tax Liabilities	-	-	-	1.42	-	-
Other Long-Term Liabilities	-	-	-	-	-	2.24
Total Liabilities	506.07	516.59	440.92	240.99	232.89	366.78
Common Stock	375.93	375.93	379.16	372.51	322.59	322.59
Additional Paid-In Capital	904.49	903.73	912.8	888.99	630.63	619.94
Retained Earnings	333.15	324.3	455.64	444	399.25	363.59
Treasury Stock	-14.33	-14.33	-27.92	-	-	-
Total Common Equity	1,599	1,590	1,720	1,705	1,352	1,306
Minority Interest	0.03	0.04	9.7	10	-	-
Shareholders' Equity	1,599	1,590	1,729	1,715	1,352	1,306
Total Liabilities & Equity	2,105	2,106	2,170	1,956	1,585	1,673
Total Debt	257.18	254.34	175.69	39.69	37.61	-
Net Cash (Debt)	-72.16	-64.69	193.51	514.64	205.94	456.78
Net Cash Growth	-	-	-62.40%	149.90%	-54.92%	-33.07%
Net Cash Per Share	-0.19	-0.17	0.53	1.61	0.64	1.43
Filing Date Shares Outstanding	375.93	375.93	379.16	372.51	322.59	322.59
Total Common Shares Outstanding	375.93	375.93	379.16	372.51	322.59	322.59
Working Capital	15.57	-10.81	184.96	521.99	358.67	285.73
Book Value Per Share	4.25	4.23	4.54	4.58	4.19	4.05
Tangible Book Value	1,118	1,107	1,200	1,219	850.59	792.67
Tangible Book Value Per Share	2.97	2.95	3.16	3.27	2.64	2.46
Buildings	-	373.99	372.77	372.77	371.38	439.79
Machinery	-	571.12	528.14	391.32	364.87	366.7
Construction In Progress	-	335.22	273.35	207.59	8.13	1.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.